Article Text

Download PDFPDF

Congestive heart failure adherence redesign trial: a pilot study
  1. Ashvarya Mangla1,2,
  2. Rami Doukky1,3,4,
  3. Lynda H Powell1,
  4. Elizabeth Avery1,
  5. DeJuran Richardson1,5,
  6. James E Calvin Jr6
  1. 1Department of Preventive Medicine, Rush University Medical Center, Chicago, Illinois, USA
  2. 2Department of Internal Medicine, OSF St. Francis Medical Center, Peoria, Illinois, USA
  3. 3Division of Cardiology, John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois, USA
  4. 4Division of Cardiology, Rush University Medical Center, Chicago, Illinois, USA
  5. 5Department of Mathematics, Lake Forest College, Lake Forest, Illinois, USA
  6. 6Department of Medicine, University of Western Ontario, London, Ontario, Canada
  1. Correspondence to Dr Rami Doukky; rami_doukky{at}rush.edu

Abstract

Objective Heart failure (HF) continues to be a leading cause of hospital admissions, particularly in underserved patients. We hypothesised that providing individualised self-management support to patients and feedback on use of evidence-based HF therapies (EBT) to physicians could lead to improvements in care and decrease hospitalisations. To assess the feasibility of conducting a larger trial testing the efficacy of this dual-level intervention, we conducted the Congestive Heart failure Adherence Redesign Trial Pilot (CHART-P), a proof-of-concept, quasi-experimental, feasibility pilot study.

Setting A large tertiary care medical centre in Chicago.

Participants Low-income patients (<US$30 000/year) hospitalised for exacerbation of systolic HF (ejection fraction ≤50%) and their physicians. Twenty physicians and 33 patients were enrolled, of whom 23 patients completed the study.

Interventions Physicians received HF guidelines and periodic individualised feedback on their adherence to EBT. Patients received HF education, support and self-management training for diet and medication adherence by a trained nurse through 11 interactive sessions over a 4-month period. Evaluations were conducted pre-enrolment and 1 month postintervention completion.

Outcome measures Feasibility was assessed by the ability to deliver intervention to patients and physicians. Exploratory outcomes included changes in medication and sodium intake for patients and adherence to EBT for physicians.

Results Eighty-seven per cent and 82% of patients received >80% of interventions at 1 month and by study completion, respectively. Median sodium intake declined (3.5 vs 2.0 g; p<0.01). There was no statistically significant change in medication adherence based on electronic pill cap monitoring or the Morisky Medication Adherence Scale (MMAS); however, there was a trend towards improved adherence based on MMAS. All physicians received timely intervention.

Conclusions This pilot study demonstrated that the protocol was feasible. It provided important insights about the need for intervention and the difficulties in treating patients with a variety of psychosocial problems that undercut their effective care.

  • QUALITATIVE RESEARCH

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.